Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01233518 · ClinicalTrials.gov registry record · NA

Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

A NA study, sponsored by HeartFlow.

Completed
Registry status
NA
Development phase
285
Enrollment target

NCT01233518 is a NA study that has completed, run by HeartFlow. The registered enrollment target is 285 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01233518, a NA study, has completed, sponsored by HeartFlow.

COMPLETED
Registry status
NA
Development phase
285 participants
Enrollment target

Study Summary

This is a prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic significance of coronary lesions, as compared to direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard.

Interventions

  • DEVICE FFR

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2010-10
Est. Completion 2011-11
Phase NA

Sponsor

HeartFlow

8 total trials

What the Registry Record Tells You About NCT01233518

The ClinicalTrials.gov registry entry for NCT01233518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FFR is the first listed.

NCT01233518 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01233518 about?

NCT01233518 is a clinical study titled "Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography". This is a prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic sig...

What is the current status of trial NCT01233518?

This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2010-10. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01233518?

The interventions under investigation include: FFR (DEVICE).

Who is sponsoring clinical trial NCT01233518?

This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.